CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$56.22 USD
+0.55 (0.99%)
Updated May 17, 2024 04:00 PM ET
After-Market: $55.90 -0.32 (-0.57%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -1.50 |
EPS Last Quarter | -1.43 |
Last EPS Surprise | 12.27% |
ABR | 2.17 |
Earnings ESP
|
4.48% |
---|---|
Current Year | -5.64 |
Next Year | -4.50 |
EPS (TTM) | -2.72 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.21M | 25.06M | 89.12M | 550.06M |
# of Estimates | 8 | 9 | 12 | 10 |
High Estimate | 30.30M | 114.60M | 458.40M | 3.31B |
Low Estimate | 0.30M | 7.38M | 0.50M | 70.33M |
Year ago Sales | 70.00M | 0.00M | 371.21M | 89.12M |
Year over Year Growth Est. | -88.27% | NA | -75.99% | 517.24% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.50 | -1.35 | -5.64 | -4.50 |
# of Estimates | 12 | 11 | 14 | 14 |
Most Recent Consensus | -1.39 | -1.40 | -5.00 | -5.86 |
High Estimate | -1.08 | -0.97 | -3.56 | 5.04 |
Low Estimate | -2.24 | -1.93 | -8.01 | -8.71 |
Year ago EPS | -0.98 | -1.41 | -1.94 | -5.64 |
Year over Year Growth Est. | -53.06% | 4.26% | -190.72% | 20.11% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 7 | 7 | 10 | 7 |
Up Last 60 Days | 7 | 7 | 10 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 3 | 4 |
Down Last 60 Days | 2 | 2 | 3 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.50 | -1.35 | -5.64 | -4.50 |
7 Days Ago | -1.50 | -1.35 | -5.64 | -4.50 |
30 Days Ago | -1.67 | -1.53 | -6.24 | -4.39 |
60 Days Ago | -1.67 | -1.53 | -6.24 | -4.39 |
90 Days Ago | -1.84 | -1.71 | -5.70 | -2.14 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.43 | -1.30 | -5.46 | -4.50 |
Zacks Consensus Estimate | -1.50 | -1.35 | -5.64 | -4.50 |
Earnings ESP | 4.48% | 3.21% | 3.24% | 0.04% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.43 | 1.10 | -1.41 | -0.98 | NA |
Estimate | -1.63 | -0.40 | -1.98 | -2.18 | NA |
Difference | 0.20 | 1.50 | 0.57 | 1.20 | 0.87 |
Surprise | 12.27% | 375.00% | 28.79% | 55.05% | 117.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more